Azenta (AZTA) Cash from Financing Activities (2010 - 2026)
Azenta (AZTA) recorded quarterly Cash from Financing Activities of -$1.7 million in Q1 2026, up 37.23% quarter-over-quarter from -$2.6 million in Q4 2025, and up 67.95% on a YoY basis from -$983642.3 in Q1 2025.
Azenta (AZTA) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Azenta's Cash from Financing Activities history runs 17 years deep, the most recent figure standing at -$1.7 million for Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 67.95% year-over-year to -$1.7 million; the TTM figure through Mar 2026 stood at -$9.6 million (up 98.02% YoY), while the FY2025 annual figure was -$9.6 million, up 98.55% from the prior year.
- Cash from Financing Activities was -$1.7 million for Q1 2026 at Azenta, up from -$2.6 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $1.8 million in Q3 2022 to a low of -$504.7 million in Q4 2022.
- Historically, Cash from Financing Activities has averaged -$98.1 million across 5 years, with a median of -$30.5 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities jumped 139.28% in 2022, then slumped 16399.04% in 2023.
- A 5-year view of Cash from Financing Activities shows it stood at -$504.7 million in 2022, then soared by 77.58% to -$113.2 million in 2023, then jumped by 95.47% to -$5.1 million in 2024, then surged by 48.65% to -$2.6 million in 2025, then surged by 37.23% to -$1.7 million in 2026.
- The last three Cash from Financing Activities figures came in at -$1.7 million (Q1 2026), -$2.6 million (Q4 2025), and -$128000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -1.35 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -414.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -13.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -255.24 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -308.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -50.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -48.13 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -11.00 Mn |
| 10 | Azenta | 1.06 Bn | 682.62 Mn | 62.04 Mn | -1.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.65 Mn |
| Mar 31, 2026 | -1.65 Mn |
| Dec 31, 2025 | -2.63 Mn |
| Dec 31, 2025 | -2.63 Mn |
| Jun 30, 2025 | -128,000.00 |
| Jun 30, 2025 | -128,000.00 |
| Mar 31, 2025 | -5.15 Mn |
| Mar 31, 2025 | -5.15 Mn |
| Dec 31, 2024 | -5.13 Mn |
| Dec 31, 2024 | -5.13 Mn |
| Sep 30, 2024 | -247.55 Mn |
| Sep 30, 2024 | -247.55 Mn |
| Jun 30, 2024 | -226.12 Mn |
| Jun 30, 2024 | -226.12 Mn |
| Mar 31, 2024 | -72.39 Mn |
| Mar 31, 2024 | -72.39 Mn |
| Dec 31, 2023 | -113.15 Mn |
| Dec 31, 2023 | -113.15 Mn |
| Sep 30, 2023 | -165.09 Mn |
| Sep 30, 2023 | -165.09 Mn |